Position in GNLX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$45,306
+$8,881 QoQ
Shares Held
15,052
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 72 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INTEGRITY ALLIANCE, LLC. holds $4,667,891 across 10 Biotechnology names. GNLX ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
8,983 | $2,198,768 | |
| 2 | CELC |
Celcuity Inc.
|
11,618 | $1,215,475 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
732 | $363,606 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
528 | $329,229 | |
| 5 | SLS |
SELLAS Life Sciences Group, Inc.
|
14,011 | $206,802 | |
| 6 | INCY |
Incyte Corp
|
1,804 | $204,501 | |
| 7 | GNLX |
GENELUX Corp
This page
|
15,052 | $45,306 | |
| 8 | HUMA |
Humacyte, Inc.
|
57,300 | $44,694 |
All Filings in GNLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,306 | 15,052 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $36,425 | 15,052 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $65,626 | 15,052 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $63,218 | 15,052 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $83,991 | 31,108 | Shares | Sole | 2025-05-20 | |
| No filing history on record for this holder in this stock. | ||||||